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Abstract
Background: Descriptions of dengue immunopathogenesis have largely relied on data from South-east Asia and America,
while India is poorly represented. This study characterizes dengue cases from Pune, Western India, with respect to clinical
profile and pro-inflammatory cytokines.
Methodology/Principal Findings: In 2005, 372 clinically suspected dengue cases were tested by MAC-ELISA and RT-PCR for
dengue virus (DENV) aetiology. The clinical profile was recorded at the hospital. Circulating levels of IFN-c, TNF-a, IL-6, and
IL-8 were assessed by ELISA and secondary infections were defined by IgM to IgG ratio. Statistical analysis was carried out
using the SPSS 11.0 version. Of the 372 individuals, 221 were confirmed to be dengue cases. Three serotypes, DENV-1, 2
and 3 were co-circulating and one case of dual infection was identified. Of 221 cases, 159 presented with Dengue fever (DF)
and 62 with Dengue hemorrhagic fever (DHF) of which six had severe DHF and one died of shock. There was a strong
association of rash, abdominal pain and conjunctival congestion with DHF. Levels of IFN-c were higher in DF whereas IL-6
and IL-8 were higher in DHF cases (p,0.05). The mean levels of the three cytokines were higher in secondary compared to
primary infections. Levels of IFN-c and IL-8 were higher in early samples collected 2–5 days after onset than late samples
collected 6–15 days after onset. IFN-c showed significant decreasing time trend (p=0.005) and IL-8 levels showed increasing
trend towards significance in DHF cases (interaction p=0.059). There was a significant association of IL-8 levels with
thrombocytopenia and both IFN-c and IL-8 were positively associated with alanine transaminase levels.
Conclusions/Significance: Rash, abdominal pain and conjunctival congestion could be prognostic symptoms for DHF. High
levels of IL-6 and IL-8 were shown to associate with DHF. The time trend of IFN-c and IL-8 levels had greater significance
than absolute values in DHF pathogenesis.
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Introduction
Dengue is caused by infection with any of the four closely
related serotypes of dengue virus (DENV) transmitted by Aedes
aegypti. Two-thirds of the world’s population is at risk, and about
50 million infections occur worldwide every year with a mortality
that can vary from ,1% to 20% depending on the quality of
treatment [1]. Dengue is an emergent disease in India with 5,000–
10,000 cases reported per year [2].
The clinical presentations of dengue vary from the self-
resolving dengue fever (DF) to the more severe dengue
hemorrhagic fever (DHF) or dengue shock syndrome (DSS).
Immunity to one serotype does not provide protection against
other serotypes [3]. The more severe form, DHF occurs mostly in
individuals who acquire a heterotypic secondary infection [4].
The severity of dengue varies with age of infected individuals
[5–6], the infecting DENV serotype/genotype [7–8], the immune
status [9], and the genetic makeup of the population [10].
Humoral immunity was considered as the major contributing
factor, supported by demonstration of antibody dependent
enhancement (ADE) in vitro [11], and sero-epidemiological studies
[12,13,14]. Later, cytokines and memory T cells [9] and recently
T regulatory cells [15] have also been implicated in disease
pathogenesis.
Several groups have reported increased levels of inflammatory
cytokines, i.e. IFN-c, TNF- a, IL-6 in DHF patients. Most of these
reports are based on studies in infants/children from South-East
Asia [16–20] and Tahiti [21]. In contrast, higher levels of IFN-c,
TNF-a and IL-6 have been reported in adult DF patients from
Brazil [22] and India [23,24]. Increased IL-8 levels have been
associated with DHF and DSS in both adults and children [25,26].
The significance of circulating levels of cytokines as inflammatory
mediators in dengue patients is controversial and difficult to
interpret [27]. This is probably because there is variation in the
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presentation of the cases and the genetic population. Only few
studies have correlated cytokine levels with day of illness
[17,21,25]. The present study was carried out in Pune, Western
India, endemic to dengue. We assessed the levels of inflammatory
mediators- IFN-c, TNF-a, IL-6 and IL-8 in well characterized
dengue patients in context to their clinical presentation combined
with laboratory findings, the day of illness and the immune status
of the patient.
Methods
Ethics statement
This study was approved by the National Institute of Virology
Human Ethics Committee on the basis of the guidelines laid down
by the Indian Council of Medical Research. Informed consent was
not obtained earlier as it is not required for specimens for viral
diagnosis. As the samples have already been collected, there is no
risk to the subjects except the privacy and confidentiality of the
patients, which is being taken care of by using indirect identifiers
and anonymous specimens without making any reference to
identifying information of the patients. Waiver of the informed
consent was granted by the committee on the basis of ‘‘Use of left-
over specimens after clinical investigation’’ under the Indian
Council of Medical Research Guidelines 2006.
Clinical Samples
Patients with dengue-like illness presenting to any of three
different hospitals located in three different areas of Pune - King
Edward Memorial Hospital (KEMH), Yashwantrao Chavan
Memorial Hospital (YCMH), or Deenanath Mangeshkar Hospital
(DMH), between July and December 2005, were included in the
study. From July to December 2005, our staff visited the three
hospitals, every day to bring samples collected by the hospital to
National Institute of Virology (NIV) for diagnosis. Patients with
dengue like illness were included; those with parasitic and
respiratory infections were excluded by the clinicians. Blood
samples were transported on ice, plasma was separated and
aliquoted. One aliquot was used for MAC-ELISA and RT-PCR
and the leftover aliquot was frozen at 280uC.
Of the 372 suspected dengue patients, 40 attended the out
patient department, and 332 were hospitalised. The individuals
were tested for the presence of DENV-specific IgM and/or viral
RNA and those positive by either of the two tests were considered
as dengue patients. The clinical presentations of the patients were
recorded by the clinicians of the respective hospitals, and
abstracted by chart review. Patients with fever, headache, myalgia,
retro-orbital pain, and rash were defined as DF. DHF patients
were categorized by the presence of at least two of the DHF
defining criteria of the World Health Organization [28]:
hemorrhagic tendencies/manifestations, thrombocytopenia, and
evidence of plasma leakage.
For each patient, the day of onset of fever was designated as the
first day of illness. Plasma samples collected on 2–5 days post
illness was designated as ‘early’ and 6–15 days post illness as ‘late’.
Samples from 45 age-sex matched healthy blood donors were
included as negative controls.
Haemoglobin level, total leukocyte count (TLC), packed cell
volume (PCV), platelet count, estimation of levels of aspartate
Table 1. Demographics, Serotypes detected and disease
categories.
Category Subcategory Number of cases (%)
Total number of dengue cases 221
Median Age (years) 24
Sex Males 180 (81)
Females 41 (19)
RT PCR positive cases 32 (14)
Serotypes detected
DENV-1 16 (50)
DENV-2 10 (31)
DENV-3 5 (16)
DENV-2/3 1 (3)
Dengue fever 159 (71.9)
With thrombocytopenia 81 (51)
Dengue hemorrhagic fever 62 (28)
Severe cases 7 (11)
doi:10.1371/journal.pone.0008709.t001
Figure 1. Age-wise distribution of DF and DHF cases. Number of dengue cases plotted according to age – groups.
doi:10.1371/journal.pone.0008709.g001
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phosphatase (ALP) and bilirubin were carried out at KEMH
and DMH for 95 patients. Data were obtained from the patients’
clinical charts.
Laboratory diagnosis
Blood samples from all 372 cases were tested in the laboratory
for dengue aetiology. The in-house National Institute of Virology
(NIV) IgM capture ELISA kit was used to detect DENV-specific
IgM [29]. A known positive (P) and a known negative (N) serum
control were used in every test. A sample showing an OD value
.2.1 times the P/N ratio was considered positive.
Samples were tested for presence of viral RNA and serotyped by
the multiplex nested RT-PCR. RNA was extracted from 140-ml
serum/plasma using a viral RNA extraction kit (Qiagen Sciences,
Valencia, CA, USA). Group specific primers were used in the first
cycle of the RT-PCR and serotype-specific primers were used in
the second cycle as described previously [30]. The amplicons were
sequenced for confirming the serotype detected using Big Dye
terminator kit (Applied Biosystems, Foster city, CA, USA).
Classification of primary and secondary DENV infection was
done using IgM and IgG capture ELISA kits (Panbio, Windsor,
Australia) for a subset of 123 samples depending on availability.
IgG levels of .22 units (defined by the manufacturers) or ratio of
IgM to IgG of ,1.78 indicated secondary infection [31].
Cytokine estimation
Estimation of four cytokines, Interferon-c (IFN-c), Tumor
necrosis factor-a (TNF-a), Interleukin-6 (IL-6) and Interleukin-8
(IL-8) in the plasma samples was done using the human cytokine
ELISA kits (Opt EIA Sets, BD Biosciences, USA) for the 221
confirmed dengue cases and 45 apparently healthy controls.
Standards were included in each assay and the standard curve was
used for estimation of cytokine concentration (in pg/ml) by
regression analysis. The detection limits of the kit for IFN- c, TNF-
a, IL-6, and IL-8 were 4.6, 7.8, 4.6, and 3.1 pg/ml respectively.
Table 2. Clinical signs/symptoms in DF and DHF patients.
Signs/Symptoms DF cases (n=159), n(%) DHF cases (n=62), n (%) Comparison between DHF and DF p- value
Myalgia 101 (63.5) 33(53.2) - 0.20
Headache 101 (63.5) 33(53.2) - 0.20
Nausea/Vomiting 90 (56.6) 44 (70.9) - 0.07
Cough 15 (10.8) 4 (4.9) - 0.20
Sore throat 8(5) 3(4.8) - 0.95
Itching 29 (18.2), 3 (4.8) DF.DHF 0.01
Joint pain 42 (19.5) 3 (4.8) DF.DHF ,0.001
Retro-orbital pain 34 (21.3) 2(3.23) DF.DHF ,0.001
Abdominal pain 29(18.2) 31 (50) DHF.DF ,0.001
Petechiae/Rash 31 (19.4) 26 (29.6) DHF.DF 0.001
Conjunctival congestion 7 (4.4) 14 (22.6) DHF.DF ,0.001
Thrombocytopenia 81 (50.9) 87 (91.9) DHF.DF ,0.001
Comparison between DF and DHF patients done by chi-square test, p-value ,0.05 considered significant.
doi:10.1371/journal.pone.0008709.t002
Table 3. Laboratory findings in DF and DHF.
Variable Normal range DF DHF p value
Peak hematocrit, mean %6SD 36% 39.964.3 39.965.5
Increase in hematocrit, no of cases, (%) 8/38 (21) 17/48 (35.4) 0.22
Leucocyte count, mean cells610
36SD 4000–11000/cu mm 4.162.3 4.862.7
No. of cases with leucopenia (%) 21/39 (53.8) 25/53 (47.1) 0.67
AST levels, mean6SD Upto 30U/l 1336107.1 178.36190.4
No. of cases with Increased levels of AST 29/30 (96.6) 45/46 (97.8) 0.75
ALT levels, mean6SD Upto 40U/l 105687.1 168.16243.2
No. of cases with increased levels of ALT (%) 25/32 (78.1) 39/49 (79.5) 0.90
Alkaline phosphatase levels, mean6SD Upto 275 U/l 239.46231 259.76223.7
No.of cases with increased levels of ALP (%) 9/28(32.1) 10/41 (24.3) 0.66
Bilirubin levels ,1mg% 0.8160.68 11.8673.7
No.of cases with.1 mg% 4/30(13.3) 9/46 (19.5) 0.69
Cases compared using chi-square test, p- value ,0.05 considered significant.
doi:10.1371/journal.pone.0008709.t003
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individuals plus 2 S.D. was used as the cut-off.
Data and Statistical analysis
Descriptive data were expressed as mean with SEM levels or
number (percent) of cases. The chi-square test (with Yates
correction, wherever required) was used to examine differences
in demographic and clinical characteristics of the study group. The
values of cytokine levels were corrected by adding 1 in order to
obtain log values for statistical analysis. Group comparison data
for cytokines is presented as mean with SEM levels. Univariate
ANOVA was carried out and if significance found, post-hoc
(Tukey) test was used for defining differences within groups. To
detect the significant differences between patient groups with
respect to post onset days, general linear model (GLM) was used,
including the interaction term. Pearson correlation was used to
study the correlation between the cytokine levels and clinical
findings. A p#0.05 was considered significant. All the statistical
analyses of the data were done using the SPSS 11.0 program and
graphs plotted using GraphPad Prism 5.1 (San Diego California,
USA).
Results
Patients’ characteristics
Of the 372 dengue suspected cases, 221 (59%) were confirmed
to be dengue by laboratory tests, 98% of who were hospitalized
(n=217). A total of 195 patients were positive for dengue-specific
IgM and 32 tested positive for DENV-RNA. Six samples were
positive for both viral RNA and IgM. Table 1 presents the
demographic characteristics, serotypes detected and disease
categories for the 221 cases.
The age distribution of the dengue patients is shown in Figure 1,
with the median age being 24 years (range 1–64 years). There was
a larger representation of males as indicated by the male: female
ratio of 4.4:1. The higher representation of males was reflected in
the fever cases attending the hospitals (data not shown). Of the
three serotypes (DENV-1, 2 and 3), DENV-1 was predominant
(50%).
Based on clinical features, 71.9% (n=159) of the patients were
classified as DF, 50% of them had thrombocytopenia without any
bleeding. Presence of any two of the DHF defining criteria by
WHO, categorized 62 patients as DHF cases. Seven patients were
defined as severe DHF (grades III/IV) with signs of circulatory
failure. One fatal patient had severe thrombocytopenia, plasma
leakage and circulatory failure (Grade IV). The distribution of DF
and DHF cases did not differ by age (Fig. 1). An 11-year-old boy,
who presented with DF was found to have a dual infection with
DENV-2 and DENV-3, (Table 1).
To identify possible predictors for DHF, the clinical symptoms
presented by the 221 confirmed cases common to DF and DHF
were analyzed in context to disease category (Table 2). Fever
with chills, headache, myalgia and nausea/vomiting were
reported equally by DF and DHF patients. Joint pain, retro-
orbital pain and itching were observed in a significantly larger
number of DF cases (p,0.05, x
2 test). Abdominal pain,
maculopapular rash/petechiae and conjunctival congestion were
f o u n dt ob em o r ep r e v a l e n ti nD H Fc a s e s( p,0.05, x
2 test). The
percentage of DHF patients with thrombocytopenia (92%) was
significantly higher than the percentage of DF patients (51%)
(p,0.01, x
2 test).
The metabolic parameters and hematological profiles available
for 95 samples (42 DF cases, 53 DHF cases) were also analyzed in
the context of DF/DHF (Table 3). An increase in the hematocrit
(Hct) value, $20% above the area specific cut-off levels, which is
the defining criteria for DHF by WHO, was observed in 17 DHF
patients (35.4%) and an increase of $10–19% was observed in 11
DHF patients (21%), which has also been considered as
abnormal by Nyugen et al., [32]. Both hemoconcentration and
leucopenia were observed in a larger number of DHF cases
compared to DF, but the difference was not statistically
significant. Elevated levels of AST and ALT were seen in both
DHF and DF patients.
In the total 62 DHF cases, gastrointestinal bleeding, manifested
by melena or hematemesis was reported in 32 (51.6%) cases.
Hematuria observed in six (9.7%), gum bleeding in six (9.7%),
conjunctival hemorrhage in four (6.4%) and epistaxis in two
(3.2%) patients were less common. Splenomegaly and hepato-
megaly was evidenced in 11 (17.7%) and in 7 (11.3%) cases
respectively. Plasma leakage was observed in 23 (37%) patients –
either as ascites (n=22) and/or as pleural effusion (n=16).
Levels of cytokines in dengue patients
The circulating levels of four cytokines, IFN-c, TNF-a, IL-6 and
IL-8 were assessed in the 221 confirmed dengue cases (Fig. 2).
Figure 2. Levels of IFN-c, TNF-a, IL-6 and IL-8 in DF and DHF
patients. A. Mean with SEM levels (pg/ml) of cytokines. B. Number (%)
of cases with increased (above cut-off) values of cytokines in DF/DHF.
Analysis of variance was carried out for log transformed values of each
cytokine and differences in groups analysed by using Tukey test.*p-
value ,0.05 when compared with controls. *p-value ,0.05 when
compared between DF and DHF. Comparison between number of
cases for DF and DHF done using chi-square test. p-value ,0.05 is
shown.
doi:10.1371/journal.pone.0008709.g002
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PLoS ONE | www.plosone.org 4 January 2010 | Volume 5 | Issue 1 | e8709Figure 3. Cytokine levels (pg/ml) in early and late days of illness in DF and DHF patients. Scatter plot of levels of cytokine (pg/ml) in early
(2–5) and late (6–15) days of illness. A) IFN-c, B) TNF-a, C) IL-6 and D) IL-8. The two panels show DF and DHF cases. The mean levels are indicated with
the red line. The cut-off (mean levels in healthy controls+2SD) for each cytokine is shown with a dashed line.
doi:10.1371/journal.pone.0008709.g003
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A mean level of 1.3 pg/ml of IFN-c was detected in healthy
controls. Using 3.8 pg/ml as cut off, IFN-c was found to be
significantly higher (p,0.001) in dengue patients (both DF and
DHF), with a range of 0.9 to 859.7 pg/ml. The mean level of IFN-
c in DF cases was higher compared to the mean level in DHF
patients (Fig. 2A). The number of cases showing increased IFN-c
levels was larger in the DHF category (66.1%, n=41) as compared
to DF cases (58.4%, n=93) (Fig. 2B).
TNF-a levels
The mean level of TNF-a in healthy controls was 3 pg/ml and
the cut off was 5.5 pg/ml. The concentration of TNF-a ranged
from 0 to 184 pg/ml in dengue patients (Fig. 2A,B). The mean
values of DF and DHF were lower than that of healthy controls
(p.0.05).
IL-6 levels
The mean level of IL-6 in healthy controls was 4.8 pg/ml
and 8.9 pg/ml was the cut off value. The values in dengue cases
ranged from 0.13 to 417 pg/ml. The levels of IL-6 in all dengue
cases were higher than healthy controls, but not statistically
significant (p.0.05). However, with disease categorization, the
levels of IL-6 in DHF were higher than in DF patients (p=0.02,
Tukey test). DHF cases also showed a higher mean level
(Fig. 2A) and a larger number of cases with high levels (47%)
(Fig. 2B).
IL-8 levels
The level of IL-8 in healthy controls was variable ranging from
1 to 25 pg/ml, resulting in a high cut off value of 16.26 pg/ml.
The range of values observed in dengue patients was 1 to
355.3 pg/ml and on comparison with controls significantly higher
(p,0.001). The levels in DHF were significantly higher than in DF
cases (p,0.001, Tukey test). The mean value of IL-8 (Fig. 2A) and
the number of cases with increased levels (79%) were also higher in
DHF group (Fig. 2B).
In summary, higher levels of IFN-c, IL-6 and IL-8 were
observed in dengue cases compared to healthy controls. Further-
more, the levels of IL-6 and IL-8 were significantly higher in DHF
cases as compared to DF cases.
Cytokine levels on different post onset days
We further investigated whether it was the early (2–5 days of
illness) or late (6–15 days of illness) cytokine response, which
contributed to differences observed between DF and DHF cases
using the interaction term in the general linear model of analysis.
The IFN-c levels showed a time trend (p,0.001), which did not
differ by group. The levels of IL-6 did not show a time trend.
Levels of IL-8 on the other hand showed a time trend that differed
for DF and DHF (p=0.016).
When the cytokine levels were analysed for time trend for
individual DF or DHF groups we observed that the levels of IFN-c
showed significant decreasing trend (p=0.005) and IL-8 levels
showed increasing trend towards significance in DHF cases
(interaction p=0.059).
This prompted us to compare the levels of cytokines in DF and
DHF cases during the early and late period of infection (Fig. 3).
The levels of IL-6 (p=0.005) and IL-8 (p,0.001) were found to be
significantly higher in DHF cases as compared to DF in the early
phase while the difference was not significant in late phase.
Effect of immune status of the host
Based on the criteria of 22 IgG units qualifying a secondary
infection, 62% of DF cases and 38% of DHF cases were classified
as secondary, which is contrary to the earlier findings of larger
number of secondary cases in DHF [9]. Therefore the criteria of
IgM/IgG ratio of ,1.78 to be indicative of secondary infection
[31] was used. The number of secondary cases increased in both
categories, 74% in DF cases and 85.7% in DHF cases.
The levels of the four cytokines were therefore, analysed in
context to primary versus secondary infections defined by IgM/
IgG ratio (Fig. 4). The mean levels of all four cytokines were higher
in secondary cases compared to primary cases. Higher levels of IL-
6( p=0.018) and IL-8 (p=0.06) were observed in secondary cases
compared to primary dengue cases.
Relationship between cytokines and clinical parameters
We then analysed the association between increased levels of
IFN-c, IL-6 and IL-8 with parameters indicative of cell damage,
thrombocytopenia, a correlate of platelet destruction, increased
hematocrit values, pleural effusion/ascites, indicative of endothe-
lial cell dysfunction and raised AST/ALT, suggestive of liver
Figure 4. Cytokine levels in primary and secondary DENV infections. Mean with SEM levels of four cytokines (pg/ml) in primary and
secondary infections. Patients with IgM/IgG $1.78 had primary infections; IgM/IgG,1.78 had secondary infections. p-value calculated by analysis of
variance of log transformed levels of cytokines. p,0.05 considered significant.
doi:10.1371/journal.pone.0008709.g004
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number of cases with thrombocytopenia (58.2%), increased
hematocrit (64%) and pleural effusion/ascites (50%) but the
difference was not significant when compared to levels in patients
without the manifestations. However, the association of IFN-c
levels with the ALT levels was significant (r=0.257, p=0.035)
(Fig. 5A). Increased levels of IL-6 were observed in 65% of the
patients who showed pleural effusion/ascites. IL-8 levels showed
weak association with ALT levels (r=0.358, p=0.002), (Fig. 5B).
The levels of IL-8 in dengue patients with thrombocytopenia were
significantly higher than in the patients that showed normal
platelet count (p=0.008, Tukey test), (Fig. 5C).
Discussion
In the present study, we have assessed the clinical and cytokine
profile of dengue cases in Pune in 2005. The study area is located
in Maharashtra, Western India, known to be endemic to dengue
with 600–800 cases occurring annually [2]. The reports so far
from India have mostly described DHF outbreaks in Delhi
[33,34,35]. In Pune, the representation of adults (72%) was higher
and the representation of severe cases was very low. Only 27% of
the cases could be classified as DHF, lower than that reported in
Delhi. There were multiple serotypes co-circulating, DENV-1
being the predominant serotype followed by DENV-2 and DENV-
3. Co-circulation of multiple serotypes is now being commonly
reported [36–37] and might be responsible for the increase in
occurrence of DHF. One individual who evidenced dual infection
with DENV-2 and 3 had mild disease; similar to a report from
Brazil [38] suggesting that simultaneous infection with two
serotypes does not exacerbate the disease.
Of the symptoms common to dengue infected patients, joint
pain, retro-orbital pain, and itching were seen in a significantly
higher proportion of DF cases. On the other hand rash, abdominal
pain and conjunctival congestion showed a positive association
with DHF and could be used as prognostic symptoms for DHF.
Blanching rash and abdominal pain are already considered as
strong associates of DHF [28]. Gastrointestinal (GI) bleeding
manifested by melena and hemetemesis was the most common
hemorrhagic manifestation in DHF, similar to the observations in
adult dengue cases from Thailand [5] and Srilanka [6]. Liver
involvement, which has been well documented in DHF [39], was
evidenced in 85% of the DHF patients tested.
Strict application of WHO criteria (which was formulated based
on DHF in children in South-East Asia) was found to miss many
cases of DHF [40] as shown by studies on adult population in
Nicaragua [41] and in Thailand [42]. The hospitals participating
in this study reported a difficulty in interpreting the tourniquet test,
which was therefore not included as distinguishing criteria for
DHF. Earlier reports from India found ,40% DHF cases positive
for the tourniquet test [43,44]. Thus, presence of any two of the
DHF classifying criteria by WHO - hemorrhage, hemoconcen-
tration, plasma leakage and thrombocytopenia or circulatory
collapse were used to classify DHF. Thrombocytopenia was also
detected in 48% of DF cases. We observed a fairly large
representation of secondary cases in both DF (75%) and DHF
(86%) categories. It is possible that with multiple circulating strains
in an endemic area, many individuals could acquire two infections
in a lifetime without ever experiencing severe dengue infection. At
the same time, one can also question whether the non-inclusion of
the tourniquet test resulted in inclusion of DHF I cases into the DF
category or is it that DENV still maintains its moderate virulence
in India in an endemic situation.
Figure 5. Association of cytokine levels with clinical parame-
ters of dengue patients. A. Association of levels of IFN-c with ALT
levels. B. Association of levels of IL-8 with ALT levels. C. Tukey box-
whisker plot with median, range with the upper and lower quartiles and
outliers of IL-8 levels in thrombocytopenic (platelet count ,100,000)
and non- thrombocytopenic (platelet count .100,000) dengue
patients. A & B] Pearson correlation used for analysis, p,0.05
considered significant. C] p-value calculated by ANOVA, p,0.05
considered significant. Outliers showed as dots and those above the
axis limit not shown in graph but included in analysis.
doi:10.1371/journal.pone.0008709.g005
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revealed that three cytokines, IFN-c, IL-6, and IL-8 were
significantly elevated in dengue cases as compared to healthy
controls. The levels of the four cytokines were analysed in context
of the clinical presentation, the time of sampling, and the immune
status of the DF and DHF cases to understand their relevance to
disease pathogenesis.
The levels of IFN-c were higher in DF cases compared to DHF,
as reported earlier [22–24] but a higher proportion of DHF
patients had elevated IFN-c levels, similar to findings of Kurane
et al., [16]. Analysing the data in context of day of illness, a time
trend existed for IFN-c and in DHF cases the trend from high in
the early phase to low levels in the late phase was significant. The
early IFN-c response is believed to be important in DHF, peak
levels being found to precede the onset of plasma leakage [17]. In
our study, increased levels of IFN-c were found in larger number
of DHF cases with plasma leakage and showed weak association
with raised ALT levels, suggesting a potential role for IFN-c in
dengue pathogenesis.
In contrast to other studies in which elevated levels of TNF-a
were reported in patients with DHF and DSS [17,45,46], the levels
of TNF-a observed in our study were very low. This was probably
because the sampling was not early enough and the severity of
disease was milder with very few cases of DHF III/IV. In addition,
it is possible that genetic polymorphism in the TNF-a gene may be
a contributing factor [47,48].
Comparison of the levels of IL-6 in DF versus DHF cases
revealed that the DHF cases had significantly higher values. IL-6
was also associated with presence of pleural effusion/ascites in
DHF, consistent with an earlier report [19] but not with
thrombocytopenia or increased ALT.
The level of IL-8 seemed more relevant to DHF pathogenesis,
not only was it significantly higher in DHF compared to DF but
also correlated with thrombocytopenia and raised ALT. Recent
study has shown up-regulation of the genes expressing pro-
inflammatory cytokines including IL-6 and IL-8 in HepG2 cells in
vitro. [49]. Increased levels of IL-8 have been associated with
plasma leakage [18,26,50,51].
Unique to our study, a time trend for IL-8 levels was found in
early to late post-onset day of illness in DHF cases. In addition,
together with IL-6, the early levels of IL-8 were higher in DHF as
compared to DF cases.
Higher levels of all four cytokines were observed in secondary
infections as compared to primary infections. This supports the
relevance of enhanced cytokine secretion in the T-cell mediated
immunopathology of secondary DENV infection [9].
Conclusion
Our study has provided the clinical picture of dengue cases in
Pune, along with the cytokine responses. DHF is seen in 27% of
the cases with low severity despite the circulation of multiple
serotypes. It suggests that abdominal pain, rash and conjunctival
congestion could be considered as warning symptoms for
development of DHF and confirms the hepatic involvement in
adult DHF cases. Higher levels of IL-6 and IL-8 early in course of
infection may be prognostic markers for progression to DHF and
seem to play a role in the disease pathogenesis.
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